Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Cerulean Announces Technology Platform Collaboration with Novartis
Thursday, October 20, 2016Cerulean Pharma Inc a clinicalstage company developing nanoparticledrug conjugates NDCs today announced that the Company has entered into a strategic collaboration with Novartis to develop NDC product candidates combining Ceruleans proprietary Dynami...
Sun Pharma, ICGEB tie up to develop dengue vaccine
Wednesday, October 19, 2016Durg major Sun Pharma today announced a new collaboration with International Centre for Genetic Engineering and Biotechnology ICGEB for development of dengue vaccine targeted against all four serotypes of the virus Sun Pharma will fund and support f...
Roche's lung cancer drug wins U.S. approval
Wednesday, October 19, 2016Swiss drugmaker Roche Holding AGs new immunotherapy Tecentriq won approval on Tuesday from US health regulators as a secondline lung cancer treatment a decision seen likely to erode BristolMyers Squibbs position in this hotly contested market The US...
FDA accepts AstraZeneca's new Hyperkalaemia drug application for review
Tuesday, October 18, 2016FDA accepts for review new drug application for sodium zirconium cyclosilicate zs for the treatment of Hyperkalaemia FDA has indicated that this is a complete class response Interactions with other health authorities in European Union and Australi...
Indalo Therapeutics Formed by Merger of Antegrin and Cascadia
Tuesday, October 18, 2016Antegrin Therapeutics and Cascadia Therapeutics announced the formation of Indalo Therapeutics a biotechnology company dedicated to developing novel therapies to treat fibrotic diseases The entity results from the merger of Antegrin and Cascadia and...
FDA places Regeneron and Teva's pain-drug study on hold
Tuesday, October 18, 2016Regeneron Pharmaceuticals Inc and partner Teva Pharmaceutical Industries Ltd said the US health regulator placed a clinical hold on a study testing their pain treatment dealing another blow to companies looking to develop a safer alternative to opioi...
Celgene Crohn’s Drug Benefit Supported by Image Data in Trial
Monday, October 17, 2016Celgene Corps experimental pill for Crohns disease helped more patients than analysts expected reinforcing positive results of an earlier study and likely boosting investors confidence in the drugs chances of approval Thirtyseven percent of patients...
Cipla signs deal to set up first biosimilars unit in South Africa
Monday, October 17, 2016Indian pharmaceutical major Cipla has signed a memorandum of agreement for South Africas first biosimilars manufacturing facility to be set up at a cost of nearly million The agreement with KwaZuluNatal Dube Trade Port Special Economic Zone for Cip...
TiGenix Announces Orphan Drug Designation (ODD) for Cx601 in Switzerland
Monday, October 17, 2016TiGenix NV an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic expanded stem cells today announced that Cx its lead product candidate being developed for the...
Osiris Therapeutics says commenced steps to terminate enrollment in OTI-15-01 phase III clinical trial
Saturday, October 15, 2016Osiris Therapeutics Inc says on October company commenced steps to terminate enrollment in its OTI phase III clinical trial Osiris trial was investigating safety and efficacy of OTI in patients suffering from chronic DFUS that have not responded t...
